MedTrace Logo

Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

NCT00648310 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2008-04-01

No results posted yet for this study

Summary

Despite the great number of reports about the efficacy of oestrogens or antimuscarinics on OAB symptoms, so far no author has tried to investigate whether the concomitant administration of these two drugs, acting on two different pathophysiological mechanisms, could have a synergic effect reducing the rate of non-responders to treatment.

Conditions

Interventions

DRUG

Tolterodine 4 mg

DRUG

arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2007-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00648310 on ClinicalTrials.gov